SEC Form 4 · accession 0001179110-18-007122
USANA HEALTH SCIENCES INC · USNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Mulham Mulham
Officer — Chief Field Development Office
Period of report
May 16, 2018
Accepted (ET)
May 18, 2018 · 4:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000896264
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 16, 2018 | M | 14,733 | $70.745 | A | 14,733 | D | |
| Common StockF2 | May 16, 2018 | S | 4,855 | $112.4708 | D | 9,878 | D | |
| Common StockF3 | May 16, 2018 | S | 9,878 | $113.3039 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock - Settles Stock Appreciation Right | $70.745 | May 16, 2018 | M | 40,000 | D | Sep 1, 2017 | Mar 1, 2020 | Common Stock | 40,000 | 60,000 | D |
Explanation of responses
- F1The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II.
- F2Weighted average price $112.4708. Price range in multiple transactions was $112.00 to $112.9501 inclusively.
- F3Weighted average price $113.3039. Price range in multiple transactions was $113.10 to $113.55 inclusively.